4‐Formyl‐N‐Methylpyridinium‐Mediated N‐Terminal Cysteine Modification/Removal Facilitates One‐Pot Multiplex Peptide Ligation

B Bingcheng Wei (Center for Chemical Glycobiology, Shanghai Key Laboratory for Antibody-Drug Conjugates with Innovative Target, State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering) X Xinyao Wang (Biomedical Pioneering Innovation Center) F Farong Ye (Center for Chemical Glycobiology, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Zhangjiang Institute for Advanced Study, School of Pharmaceutical Sciences) H Haozhan Wang (The First Affiliated Hospital of Harbin Medical University, School of Stomatology Harbin Medical University Harbin China) G Gongyu Shi (Center For Chemical Glycobiology Shanghai Key Laboratory For Antibody‐Drug Conjugates With Innovative Target National Key Laboratory of Innovative Immunotherapy Zhangjiang Institute for Advanced Study School of Chemistry and Chemical Engineering Shanghai Jiao Tong University Shanghai China) B Bing Liu P Ping Huang P Ping Wang

Abstract

ABSTRACT The chemical synthesis of proteins with site‐specific modifications remains a fundamental challenge in chemical biology. One‐pot peptide ligation strategies have emerged as powerful tools to enhance synthetic efficiency, primarily relying on N‐terminal cysteine (Cys) protection. However, current Cys deprotection conditions require various reagents or pH adjustments during the reaction, rendering downstream processing cumbersome. Here, a visible‐light‐mediated deprotection strategy using 2‐(N‐methylpyridinium‐4‐yl)‐thiazolidine (4‐NMP‐Thz) as a novel N‐terminal Cys‐protecting group is reported. This reaction, catalyzed by [Ru(bpy) 3 ]Cl 2 at physiological pH (6.0–8.0), enables smooth one‐pot multi‐segment peptide assembly. The strategy demonstrates complete orthogonality to native chemical ligation (NCL) and desulfurization conditions, eliminating the requirement for intermediate purification or pH adjustment. This methodology was used to facilitate an efficient one‐pot synthesis of a 400‐amino acid (aa) glycosylated MUC1 glycoprotein bearing 40 O‐glycosyl modifications that is difficult to prepare using previously reported techniques. The 400‐aa MUC1 significantly enhanced antigenic immunogenicity compared with shorter MUC1 glycopeptides. This streamlined approach establishes a robust platform for the construction of complex post‐translationally modified proteins.

Article Details

Volume / Issue Vol. 1, Issue 1
Published June 13, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (8)

B

Bingcheng Wei

Center for Chemical Glycobiology, Shanghai Key Laboratory for Antibody-Drug Conjugates with Innovative Target, State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering

X

Xinyao Wang

Biomedical Pioneering Innovation Center

F

Farong Ye

Center for Chemical Glycobiology, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Zhangjiang Institute for Advanced Study, School of Pharmaceutical Sciences

H

Haozhan Wang

The First Affiliated Hospital of Harbin Medical University, School of Stomatology Harbin Medical University Harbin China

G

Gongyu Shi

Center For Chemical Glycobiology Shanghai Key Laboratory For Antibody‐Drug Conjugates With Innovative Target National Key Laboratory of Innovative Immunotherapy Zhangjiang Institute for Advanced Study School of Chemistry and Chemical Engineering Shanghai Jiao Tong University Shanghai China

B

Bing Liu

P

Ping Huang

P

Ping Wang